Roche Expands HPV Testing for Cobas 5800 Molecular System
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read MorePosted by Andy Lundin | Nov 6, 2023 | Cervical (HPV), Molecular Diagnostic Analyzers |
Roche announced the U.S. FDA approved the cobas HPV test for use on its next-generation cobas 5800 molecular instrument.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Cancer |
The TruSightf Oncology 500 ctDNA v2 enables comprehensive genomic profiling of ctDNA from blood when tissue testing is not available.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Cervical (HPV), Molecular Diagnostics |
Abbott received FDA approval for its molecular HPV screening solution for its Alinity m family of diagnostic assays.
Read MorePosted by Andy Lundin | Nov 2, 2023 | Information Technology |
Genomenon says it is delivering a catalog of more than 9,000 gene-disease relationships across 5,500 genes, with more being added each week.
Read MorePosted by Andy Lundin | Nov 1, 2023 | Specimen Collection & Handling |
YourBio Health received further regulatory approval for its TAP Micro Select blood collection device with certification for CE Marking.
Read More